Trial intelligence / Profile preview

Ketamine, fentanyl and paracetamol for hemodynamic stability and acute postoperative pain after deep vitrectomy

IRCT20201213049697N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Dec 2020
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of ketamine, fentanyl and acetaminophen in retinal detachment and diabetic retinopathy (DR) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Hemodynamic parameters during and after deep vitrectomy and Acute postoperative pain after deep vitrectomy. Started Dec 2020; status: completed.

02

Drugs

ketaminefentanylacetaminophen
03

Conditions

retinal detachmentdiabetic retinopathy (DR)

Beyond the preview

Go deeper on IRCT20201213049697N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20201213049697N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call